Key facts
Active ingredient
Methylphenidate hydrochloride
Release
Modified release, equivalent to Concerta XL
Typical duration
Up to 12 hours
Frequency
Once daily, in the morning
Prescribed by
Brand name, on MHRA advice
UK licence
Children from six, and adults
Legal status
Schedule 2 controlled drug
What Xaggitin XL is
Xaggitin XL is a modified-release brand of methylphenidate licensed in the UK. It is bioequivalent to Concerta XL, which means it is designed to deliver the same amount of drug into the bloodstream over the same period.
Like Concerta XL, it is taken once in the morning and provides cover for up to twelve hours, with a portion released immediately and the remainder delivered gradually. It is swallowed whole rather than crushed, split or chewed, because that would release the full dose at once.
Most people encounter it as an alternative when Concerta XL is unavailable or when a prescriber or supplier uses it as standard, and the practical experience is intended to be the same.
What bioequivalent actually means
Bioequivalent means the product has been shown to deliver the same active ingredient into the bloodstream at the same rate and to the same extent as the reference product. It is a measured, regulated standard rather than a marketing claim.
It is not the same as saying the products are interchangeable in practice. The MHRA advises that modified-release methylphenidate is prescribed by brand name, and that advice applies to bioequivalent products too.
Why brand still matters
Bioequivalence is established as an average across a study population. Individual responses can still differ, and people do sometimes report that a switch felt different. Prescribing by brand means any change is deliberate and can be discussed, rather than happening silently at the pharmacy counter.
If your supply changes from Concerta XL to Xaggitin XL or the reverse, it is worth mentioning at your next review, particularly if anything about your day has changed since.
Dosage and duration
Xaggitin XL is taken once daily in the morning, with or without food, and swallowed whole. The dose is adjusted in steps at intervals of about a week with a review at each stage, as set out in our guide to titration.
Cover typically extends up to twelve hours. Because the delivery system does not dissolve completely, the shell may be visible in the stool. That is expected and does not mean the dose was not absorbed.
Controlled drug
Methylphenidate is Schedule 2, so it is treated differently from ordinary medicines rather than issued as a repeat prescription. Each prescription covers about a month, and identification may be requested at the pharmacy. Once your dose is stable, prescribing can sometimes move to your GP under a shared care agreement, although a practice can decline.
How Xaggitin XL compares
Twelve hours, matched to Concerta XL.
Scroll the table sideways to see every column.
The meaningful comparison is with the eight-hour products rather than with the other twelve-hour ones. If cover is running out mid-afternoon, moving from an eight-hour brand to a twelve-hour one is a real change. Moving between bioequivalent twelve-hour brands is not.
Xaggitin XL side effects
Like all medicines, this can cause side effects, and not everyone gets them. Most are mild, appear early, and settle within the first few weeks. Our general guide to ADHD medication side effects covers all the licensed options.
Common
- Reduced appetite, and sometimes weight loss
- Difficulty getting to sleep
- Headache
- Dry mouth
- Stomach ache or nausea
- Feeling anxious, restless or irritable
- A modest rise in heart rate or blood pressure
Less common
- Low mood, or mood becoming more changeable
- Tics, or existing tics becoming more noticeable
- Slowed growth in children, which is why height and weight are monitored
- Palpitations
Because cover lasts into the evening, difficulty sleeping is a more common complaint with a twelve-hour product than with a shorter one, and is often addressed by taking the dose earlier.
When to contact your prescriber
Seek medical advice promptly for chest pain, breathlessness, fainting, a fast or irregular heartbeat, signs of poor circulation in the fingers or toes, or new or worsening thoughts of self-harm. Seek advice urgently if reality starts to feel distorted, for example hearing or seeing things that are not there, believing things other people do not, or becoming unusually suspicious; or if mood becomes unusually elevated, racing or overactive with little need for sleep. Do not stop the medication abruptly without advice. Suspected side effects can also be reported through the MHRA Yellow Card scheme.
- Appetite and weight Why it happens and how it is managed
- Supply and shortages Current status and what to do
Common questions
Is Xaggitin XL the same as Concerta XL?
It is bioequivalent to Concerta XL, meaning it is designed to deliver the same drug in the same way. They are still prescribed by brand rather than treated as interchangeable.
Why was I switched to Xaggitin XL?
Usually supply. Where Concerta XL is unavailable, a bioequivalent product may be supplied instead. It is worth mentioning at your next review.
How long does Xaggitin XL last?
Up to twelve hours from a single morning dose.
Can Xaggitin XL be crushed or split?
No. It must be swallowed whole. Crushing or splitting destroys the release mechanism and delivers the full dose at once.
Is Xaggitin XL a controlled drug?
Yes. It is Schedule 2, so it is treated differently from ordinary medicines rather than issued as a repeat prescription, each prescription covers about a month, and identification may be requested at the pharmacy.
Important
This information is general and educational. It is not a substitute for medical advice. Decisions about starting, changing or stopping ADHD medication are always made together with a Consultant Psychiatrist following a full assessment.
Considering an ADHD assessment?
Any conversation about medication starts with a diagnosis. Our GMC-registered Consultant Psychiatrists assess adults and children. Assessments are £695 online and £1,095 in person in London or Manchester.
No GP referral needed. Appointments are usually available within weeks.
References
- Attention deficit hyperactivity disorder: diagnosis and management (NG87) National Institute for Health and Care Excellence
- Methylphenidate hydrochloride British National Formulary
- Methylphenidate NHS medicines A to Z
- Yellow Card scheme Medicines and Healthcare products Regulatory Agency
Last reviewed September 2026. Next review due September 2027.
